Magle Chemoswed Holding AB (OSTO:MAGLE) NonCurrent Deferred Liabilities: kr0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:MAGLE Magle Chemoswed Holding AB OSTO:MAGLE
41 GF Score
Price kr1.00
GF Value kr22.57
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Magle Chemoswed Holding AB NonCurrent Deferred Liabilities?

Magle Chemoswed Holding AB OSTO:MAGLE -12.28% 41 NonCurrent Deferred Liabilities is kr0.0 Mil as of Mar. 2026. GuruFocus rates OSTO:MAGLE with a GF Score™ of 41/100 and a GF Value™ of kr22.57 (Possible Value Trap). The stock has 6 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Magle Chemoswed Holding AB's non-current deferred liabilities for the quarter that ended in Mar. 2026 was kr0.0 Mil.

Magle Chemoswed Holding AB NonCurrent Deferred Liabilities Related Terms

Magle Chemoswed Holding AB NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Magle Chemoswed Holding AB's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Magle Chemoswed Holding AB NonCurrent Deferred Liabilities Chart

Magle Chemoswed Holding AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Magle Chemoswed Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:MAGLE
41GF Score
Magle Chemoswed Holding AB OSTO:MAGLE
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of kr0.0 Mil mean?
Magle Chemoswed Holding AB (OSTO:MAGLE) has a NonCurrent Deferred Liabilities of kr0.0 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Magle Chemoswed Holding AB and its competitors.
Is Magle Chemoswed Holding AB's NonCurrent Deferred Liabilities too high?
Magle Chemoswed Holding AB's current NonCurrent Deferred Liabilities is kr0.0 Mil. Overall, Magle Chemoswed Holding AB has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Magle Chemoswed Holding AB's NonCurrent Deferred Liabilities compare to VRTX and REGN?
Magle Chemoswed Holding AB's NonCurrent Deferred Liabilities of kr0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Biotechnology company?
A good NonCurrent Deferred Liabilities depends on the Biotechnology industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Magle Chemoswed Holding AB and its competitors. Magle Chemoswed Holding AB's current NonCurrent Deferred Liabilities is kr0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Magle Chemoswed Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Magle Chemoswed Holding AB (OSTO:MAGLE) is currently considered Possible Value Trap. The stock's GF Value™ is kr22.57, compared to a current price of kr1.00 — trading 95.6% below its estimated fair value. The current NonCurrent Deferred Liabilities is kr0.0 Mil. Magle Chemoswed Holding AB's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Magle Chemoswed Holding AB (OSTO:MAGLE), the current NonCurrent Deferred Liabilities is kr0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Magle Chemoswed Holding AB (OSTO:MAGLE) Overvalued in 2026?

Based on GuruFocus' analysis, Magle Chemoswed Holding AB stock appears to be undervalued. The current stock price of kr1.00 is trading 95.6% below its estimated GF Value™ of kr22.57. GuruFocus considers Magle Chemoswed Holding AB to be Possible Value Trap.

Key valuation signals for OSTO:MAGLE:

  • NonCurrent Deferred Liabilities: kr0.0 Mil
  • GF Value™: kr22.57 vs. price of kr1.00 (95.6% below fair value)
  • GF Score™: 41/100 with 6 warning signs

No single metric tells the full story. See the OSTO:MAGLE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Magle Chemoswed Holding AB Business Description

Other Exchanges 52X:Germany
Address Agneslundsvagen 27, Malmo, SWE, 21215
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.
41GF Score

Get the complete analysis for OSTO:MAGLE

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.00
Price
kr22.57
GF Value